HFS
DNA icon

Hopwood Financial Services’s Ginkgo Bioworks DNA Stock Holding History

Hopwood Financial Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37
Closed -$540 – 136
2025
Q3 		$540 Hold
37
– – ﹤0.01% 306
2025
Q2 		$417 Hold
37
– – ﹤0.01% 294
2025
Q1 		$211 Hold
37
– – ﹤0.01% 299
2024
Q4 		$364 Buy
+37
New +$317 ﹤0.01% 308

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hopwood Financial Services's DNA Position: Q4 2025 in Review

Hopwood Financial Services sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 37 shares — an estimated $540 sold.

Hopwood Financial Services first reported a position in DNA in Q4 2024 and held it in 4 quarters. The position peaked at $540 in Q3 2025. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Hopwood Financial Services reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Hopwood Financial Services sold 37 Ginkgo Bioworks shares in Q4 2025, an estimated $540.
  • Hopwood Financial Services first reported a position in Ginkgo Bioworks in Q4 2024 and held it in 4 quarters.
  • Hopwood Financial Services's Ginkgo Bioworks position peaked at $540 in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Hopwood Financial Services's 13F filing for Q4 2025, filed 16 Jan 2026.